1nhaler Ltd is a drug-delivery platform developer, headquartered in Edinburgh and registered with Companies House, company number SC573454.

We work closely with pharmaceutical organisations and public health bodies helping to make life-saving drugs available to more people around the world.

We are committed to conducting our business ethically and with integrity, adopting a zero-tolerance approach to modern slavery and human trafficking.

We have implemented policies and procedures to ensure these practices do not occur in our own operations or in our supply chain, including clear expectations for suppliers. These include:

Equality and diversity, grievance & dispute and anti-harassment and bullying policies
Anti-bribery and corruption policy
Anti-slavery policy
Procurement policies requiring suppliers' compliance with all applicable laws and regulations.

Regular reviews, employee training and a whistleblowing channel support our commitment. Should any risk or non-compliance be identified, we will take prompt corrective actions.

This statement is produced in compliance with Section 54 of the Modern Slavery Act 2015. It has the full approval of the board of director for 1nhaler and is signed on their behalf by the CEO and director, Lisa McMyn, November 2026.